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Abstract The human H19 is paternally imprinted (maternally
expressed). It is transcribed by RNA pol II, but has no protein
product. Its function is unknown. We showed that the transcrip-
tion of the human H19 gene is under the simultaneous control of
both a 5P upstream (promoter) region and a 3P downstream
region in cell lines derived from human choriocarcinomas.
Moreover, the activation of the H19 promoter by retinoic acid
in cells derived from human testicular germ cell tumors is
dependent upon the 3P downstream region. The possibility that
the action of retinoic acid on the H19 promoter is an indirect one
and involves a member of the AP2 transcription factor family is
discussed.
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1. Introduction
The H19 gene was ¢rst described as a gene expressed in the
mouse liver which shared a common control mechanism with
the K-fetoprotein gene [1]. The human H19 is paternally im-
printed (maternally expressed) and located on chromosome
11p15.5. This region is now known to include at least six
additional imprinted genes. In the human the H19 gene is
highly expressed in several embryonic and fetal tissues, includ-
ing the fetal adrenal, liver, and in the placenta [2,3]. Expres-
sion is nearly completely down-regulated postnatally but it is
interesting to note that H19 is expressed in the adult in the
endometrium during the luteal phase of the menstrual cycle
[4].
The H19 gene is transcribed by RNA pol II, its primary
transcription product undergoes processing and is transported
to the cytoplasm. The H19 gene very likely does not code for
a protein [5]. Both human and mouse H19 RNAs have open
reading frames (ORFs) which can potentially code for 256
and 132 amino acid long peptides, respectively. However,
there does not exist any similarity between the two amino
acid sequences which can be predicted. Nothing de¢nite is
known about the function of the H19 RNA. A tumor sup-
pressor role was proposed for the H19 gene [6] but in our
studies and that of others evidence has been provided which
contradicts this proposal. The H19 gene is expressed in a wide
variety of carcinomas, such as bladder carcinoma [7], lung
cancer [8], hepatocellular carcinoma [9] and testicular germ
cell tumors [10]. Moreover, upon injection of cells from clones
derived from choriocarcinoma cell lines (JAr and JEG-3) into
nude mice, tumors were formed which expressed enhanced
levels of H19, including cases in which the cells injected did
not express detectable H19 mRNA when grown in culture
[11]. Similar results were obtained upon injection of cells of
di¡erent human bladder carcinoma derived cell lines into nude
mice [12]. All these observations led us to the conclusion that
the H19 gene is not a tumor suppressor gene as has been
previously claimed [10,13].
Little is known about the regulation of the human H19
transcription. The H19 promoter activity in the mouse is
under the control of 5P upstream regulatory elements and 3P
downstream region(s) located between 5 and 6.5 kb 3P of the
polyadenylation site [14]. We found that cAMP and agents
which induce cAMP formation and activate protein kinase A
(ACTH, cholera toxin, forskolin) increase the H19 RNA level,
while a protein kinase C activating agent, such as TPA, de-
creases the H19 RNA level in primary human fetal adrenal
cells [15].
It is known that the sequences of the human and mouse
H19 5P upstream regions, which carry paternal speci¢c meth-
ylation patterns, di¡er widely [16,17].
In this work all our experiments deal with either the contact
human H19 gene or with 5P upstream and 3P downstream
regions derived from the human gene, using cell lines of hu-
man origin. This work is part of a program to study the
interaction between 5P upstream and 3P downstream regions
of the human H19 gene which govern the regulation of the
human H19 promoter activity. This interaction will very prob-
ably di¡er from that in the mouse because of the above men-
tioned species speci¢ty of the 5P upstream regulatory regions
of the H19 gene.
Retinoic acid plays an important role in the establishment
of the di¡erentiation pattern during embryogenesis. In cells
retinoic acid binds to one (or more) members of the retinoic
acid receptor family. Some of the genes regulated by these
receptors code for transcription factors. Therefore retinoic
acid can a¡ect the transcription level of genes by a direct or
indirect mechanism [18]. NT2 cells (derived from a human
testicular germ cell tumor) do not express the H19 gene. Ret-
inoic acid induces H19 expression in these cells [19]. There-
fore, it is possible that H19 RNA mediates, at least partly, the
e¡ect of retinoic acid on the di¡erentiation of various tissues
during embryogenesis, especially in the light of our previous
¢nding that the H19 expression level is positively correlated
with the di¡erentiation stage of placental cytotrophoblasts
both in vivo and in vitro [20]. One of the aims of the present
studies is to investigate the regulation of the human H19 gene
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transcription by 5P upstream and 3P downstream regions in
the presence of retinoic acid.
2. Materials and methods
2.1. Cell culture
The NT-2 and NCCIT cell lines were maintained in DMEM-F12
(1:1) medium containing 10% fetal calf serum (inactivated, 55‡C for
30 min), 25 mM HEPES (pH 7.4), penicillin (180 units/ml), strepto-
mycin (100 Wg/ml) and amphotericin B (0.2 Wg/ml). 4U104 cells/cm2
were plated in polystyrene culture dishes (NUNC). Every 4 days the
cells were trypsinized with 0.05% trypsin-EDTA solution (Beit Hae-
mek) for 15 min and replated again at the same initial density. 2U105
cells were seeded in 30-mm wells and grown for four days. Every 24 h
the cells from two wells were harvested as described above and
counted.
2.2. Preparation of the probe for H19 RNA detection
A region of 800 bp upstream from the poly(A) site of the human
H19 gene was subcloned into the polylinker sites of EcoRI and Hin-
dIII of the Bluescript II SK plasmid (Stratagene) between the T7 and
T3 RNA polymerase binding sites. The plasmid was linearized by
digestion with HindIII. Antisense and sense RNA transcripts labeled
with DIG nucleotides were produced in vitro, using the Amersham
Kit, T7 and T3 RNA polymerases from Boehringer (Mannheim) ac-
cording to the manufacturer’s instructions. The fragments were sepa-
rated from unincorporated nucleotides by ethanolic precipitation.
2.3. Northern blotting
Total cellular RNA was isolated from cells according to [21]. Five
or 10 Wg of each RNA sample was separated by 1% agarose-form-
aldehyde gel electrophoresis and transferred to Hybond-N Nylon ¢l-
ters (Amersham, England). The blots were stained with methylene
blue, in order to ascertain that equal amounts of RNA had been
loaded in each lane. The blots were prehybridized at 60‡C in 50%
formamide, 5U SSPE, 5U Denhardt solution, 0.1% SDS with 0.1
mg/ml herring testes DNA followed by hybridization with speci¢c
probes for 16 h. The detection was done by the alkaline phosphatase
method from the DIG Nucleic Acid detection kit (Boehringer). Sense
H19 RNA was used for control and failed to produce any signal.
2.4. Plasmids
The control plasmids pCAT-basic and pCAT-enhancer vectors were
purchased from Promega. Control plasmid pCAT-basic (Cat. No. E
1041) lacks eukaryotic promoter and enhancer sequences and the
pCAT-enhancer vector (Cat. No. E 1021) contains an SV40 enhancer
element built into the plasmid backbone. The H19 promoter plasmids
were prepared as follows. A region of 814 bp immediately upstream of
the human H19 transcriptional start site was ampli¢ed by polymerase
chain reaction (PCR) as described in [22] and cloned into the com-
mercial reporter-gene vectors (Promega). A genomic SacI fragment (5-
kb length, mentioned as the 3P downstream region), which contained a
300-bp sequence with homology at least to one of the mouse H19 3P
enhancer regions, was donated by S. Tilghman, Princeton, USA and
ligated 3P to the CAT gene.
2.5. Transfections
A total of 0.3U106 cells in 30-mm dishes were transfected with 7 Wg
of plasmid using the calcium phosphate precipitation method [23].
The precipitates were added to the cells with 1 ml of the usual growth
medium. After 16 h of incubation, the medium was changed to fresh
normal medium, with or without all-trans or 9-cis retinoic acid. Con-
trol cells received normal medium with 0.1% ethanol.
2.6. CAT assay
After 24^96 h of culture, cells were harvested and lysed. Aliquots
containing equal amounts of protein were analyzed for CAT activity,
using butyryl CoA as substrate, according to the organic phase ex-
traction procedure [24].
3. Results
The expression of the H19 gene in the mice is under the
control of both 5P upstream and 3P downstream sequence
elements. It was shown that for maximal expression both
the promoter region and the 3P enhancer regions were obliga-
tory in mouse cells from endodermal and mesodermal origin
[14]. We prepared CAT constructs in which CAT transcrip-
tion was under the control of the human H19 gene 5P up-
stream (3814 to +5) and/or a 5-kb downstream region (+6
to +11 kb) as presented in Fig. 1.
The choriocarcinoma cell lines JAr and JEG-3 were transi-
ently transfected with these constructs. The cells were incu-
bated for 48 h and CAT activity measured (Fig. 2). The 5P
upstream region alone caused a small increase in the CAT
activity, but no activity of the CAT enzyme could be detected
in cells in which the CAT gene was under the control of the
H19 3P downstream region alone. However, a considerable
increase in the CAT activity was observed when both the
H19 promoter region and the 3P downstream region were in-
cluded in the CAT expression construct. In JEG-3 cells there
was a 6.0^6.5-fold increase in CAT activity and in JAr-cells a
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Fig. 1. A schematic presentation of the insertions introduced in the
CAT reporter plasmid (Promega, USA).
Fig. 2. Enhancement of the CAT reporter gene activity by H19 5P
and 3P downstream sequences in JAr and JEG-3 cells. JAr and
JEG-3 cells were transiently transfected with the plasmids presented
in Fig. 1. The cells were collected after 48 h and CAT activity was
analyzed. The CAT activity obtained by the H19 5P region (pro-
moter) alone is designated as 1. Nearly equal results were obtained
from four independent experiments.
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2.0^2.5-fold increase due to the presence of the 3P downstream
region. The 3P region exhibited its stimulatory e¡ect when
inserted in the plasmid both in a direct and reversed orienta-
tion. The SV40 enhancer showed a higher stimulatory activity
than the H19 3P downstream region sequence in both the
JEG-3 and JAr cells. These observations show unequivocally
that the human H19 gene transcription similar to that of the
mouse H19 gene is under the control of 3P downstream re-
gions which cooperate with H19 promoter 5P upstream re-
gions.
We also investigated the e¡ect of retinoic acid on the acti-
vation of the H19 promoter by an H19 3P downstream region,
in JAr cells transfected with the appropriate CAT constructs.
However, the addition of retinoic acid to the medium of the
transfected cells did not cause any increase in the CAT activ-
ity (data not shown). We showed before that retinoic acid
stimulates H19 expression in NT-2 cells which are embryonic
stem cells derived from a human testicular tumor which do
not express the H19 gene in the absence of retinoic acid [19].
All-trans retinoic acid induces the expression of H19 in these
cells as can be seen from Fig. 3. Maximal increase was ob-
served after the cells were incubated for 96 h in the presence
of retinoic acid. During the 96 h of incubation the number of
cells increased between 4- and 6-fold, both in the absence and
in the presence of retinoic acid. This was determined by
counting the number of the cells in each well as a function
of incubation time (results not shown). In the NCCIT cell line
a similar phenomenon was observed, however, the kinetics of
the induction of H19 expression was considerably slower. H19
expression was still negligible after 72 h of incubation and was
low after 96 h, but continued to increase for at least up to
8 days (Fig. 4). It is interesting to note that in the cells of the
two cell lines, two additional bands hybridizing with our H19
antisense probe appeared in addition to the ‘normal’ 2.3-kb
H19 band. Retinoic acid induces the three above mentioned
transcripts with similar kinetics. However, in JAr cells we
have also encountered three bands in the absence of retinoic
acid treatment [11]. We do not know the nature of these
RNAs. They do not hybridize with an antisense probe di-
rected against the sense RNAs derived from the 814-bp long
H19 5P upstream region.
In order to gain more information about the mode of the
retinoic acid stimulatory action on the human H19 promoter
activity, NT-2 and NCCIT cells were transiently transfected
with the di¡erent constructs described in Fig. 1. In the two
transfected cell lines the activity obtained from the reporter
gene showed a low but consistent increase when both the 5P
H19 upstream and 3P downstream regions were included in
the CAT reporter gene construct. As can be seen from Figs. 5
and 6, both the H19 5P upstream region and the H19 3P down-
stream region alone are not su⁄cient to promote H19 expres-
sion either in the absence or in the presence of retinoic acid in
both cell lines. The addition of retinoic acid to those cells,
however, caused a very signi¢cant additional increase in the
CAT enzyme activity obtained from constructs containing
both the 5P upstream and the 3P downstream regions. Retinoic
acid had no e¡ect at all on the CAT activity in cells with
constructs from which the 3P downstream region was omitted
(Figs. 5 and 6). Yoo-Warren et al. [14] reported similar results
using 5P upstream and 3P downstream regions of the mouse
H19 genes in the PC13 mouse embryonal carcinoma cell line.
Two di¡erent 3P region constructs were used in our experi-
ments, one with the 3P region sequence in the direct, the sec-
ond one in the reverse direction. CAT constructs with the 3P
region in the reverse direction had a higher activity than the
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Fig. 3. Induction of H19 expression by all-trans retinoic acid in
NT-2 cells as a function of incubation time. Shown are Northern
blots of NT-2 RNA derived from cells cultivated in the absence (A)
or in the presence of 10 WM all-trans retinoic acid (B). The numbers
above the lanes indicate incubation time (days).
Fig. 4. Induction of H19 expression by all-trans retinoic acid in
NCCIT cells as a function of incubation time. Shown are Northern
blots of NCCIT RNA derived from cells cultivated in the absence
(A) or in the presence of 10 WM all-trans retinoic acid (B). The
numbers above the lanes indicate incubation time (days).
Fig. 5. Activation of CAT expression by H19 5P upstream promoter
and 3P downstream sequences in NT-2 cells in the absence or pres-
ence of all-trans retinoic acid. The cells were transiently transfected
with plasmids presented in Fig. 1. The cells were collected after 72
h and CAT activity was analyzed. The CAT activity obtained by
the H19 promoter alone is designated as 1. Identical results were
obtained in two independent experiments.
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CAT constructs containing the 3P region in the direct orienta-
tion (Figs. 5 and 6) in six independent experiments. The in-
ducing e¡ect of retinoic acid on CAT activity in the NT-2 cells
was higher than that in the NCCIT cells (10-fold and 5-fold,
respectively, Figs. 5 and 6). In one exceptional case we ob-
tained a negative retinoic acid e¡ect with a CAT construct
under the control of both SV40 promoter and SV40 enhancer
in NCCIT cells (Fig. 6). Since the transfection was a transient
one, we could not extend the experiments for more than
4 days. The di¡erence in the level of the induced CAT activity
in the two cell lines is very likely related to the observed
di¡erence in the kinetics of endogenous H19 RNA accumu-
lation as shown in Figs. 3 and 4, which clearly show that the
maximal H19 RNA level appears much earlier in NT-2 cells
than in NCCIT cells. We routinely used retinoic acid at a 1035
M concentration but the retinoic acid e¡ects were not smaller
at 1036 M. Moreover, 9-cis retinoic acid was as active as all-
trans retinoic acid in the promotion of the reporter gene ac-
tivity (results not shown).
4. Discussion
As previously reported by us, we isolated di¡erent clones
from JEG-3 cell lines that showed large di¡erences in their
H19 RNA levels [11]. When two of these clones, which di¡er
greatly in their H19 RNA levels, were transfected with the
constructs mentioned above, a 6-fold increase in CAT activity
was induced by the 3P downstream region, in both transfected
clones, independent of the H19 RNA level in the correspond-
ing untransfected clones. The CAT activity in the cells trans-
fected with the CAT expression constructs does not therefore
bear a direct relationship to the H19 RNA level in the cell. A
possible explanation of these ¢ndings is that the 5P upstream
and 3P downstream regions used in our experiments do not
contain all the regulatory sequences involved in the control of
H19 expression in the JEG-3 cells.
In this work we have also studied the e¡ect of retinoic acid
on the activity of the H19 gene promoter. Since retinoic acid
has no in£uence on the H19 RNA level in choriocarcinoma
cells, we studied the regions necessary for an increase in the
H19 promoter activity by retinoic acid in NT-2 and NCCIT
cell lines. These cells are derived from human testicular germ
cell tumors and express the H19 gene after addition of retinoic
acid to the culture medium (Figs. 3 and 4). In NT-2 cells the
level of H19 RNA reaches its peak after 4 days of incubation
in the presence of retinoic acid, while growth of NT-2 cells
was only slightly slowed down during the ¢rst four days of
incubation at the time of maximal H19 induction, indicating
that H19 RNA accumulation precedes growth inhibition.
Under the same incubation conditions, growth was completely
inhibited by retinoic acid only after 2.5 weeks. Therefore H19
expression is not the result of growth inhibition. On the other
hand, one cannot conclude from these results that H19 ex-
pression per se promotes growth inhibition.
A striking ¢nding of this work is that retinoic acid induces
not only the 2.3-kb H19 RNA but also the two additional
RNAs of þ 4.8 and 9.5 kb length which reacted with the
H19 probe. These RNAs hybridize with our antisense H19
probe which has a sequence complementary to an 800-bp
long sequence upstream of the polyadenylation site of the
H19 RNA but do not hybridize with an 819-bp long antisense
probe deduced from the 3814 to +5 region of the H19 gene.
Therefore these RNAs are likely formed by a transcriptional
readthrough mechanism using alternative downstream poly-
adenylation sites.
Retinoic acid may a¡ect the H19 transcription level either
in a direct or indirect way, but our results indicate that reti-
noic acid acts on H19 promoter activity in NT-2 and NCCIT
cells in an indirect way. This conclusion is based upon our
observation on the slow accumulation of the H19 RNA in the
NT-2 cells and, even more strikingly, in the NCCIT cells
(Figs. 3 and 5). Therefore it is possible that the e¡ect of
retinoic acid is mediated by (a) transcription factor(s) induced
by retinoic acid. Likely candidates are transcription factors of
the AP-2 family. AP-2.2 was shown to be induced directly by
retinoic acid in the mouse embryonal carcinoma cell line P19,
the same cell line used in the experiments of Yoo-Warren et
al. [14]. Peak levels of the AP-2.2 RNA were detected in
mouse P19 cells after 6^12 h [25]. AP.2 seems to be the medi-
ator of the e¡ect of retinoic acid on the expression of the CB-
RAP gene in mouse chondrocytes [26]. In NT-2 cells, the cell
line we have used in the described study, human AP-2 level
was found to reach a peak level 48^72 h after the addition of
retinoic acid [27], before the maximal increase in H19 RNA
level. In the human H19 5P upstream region we noted at least
2 sites (around 3500 and 340) with sequences nearly identical
to the AP-2 consensus motif (a ¢t of 8 out of 9 nucleotides).
Therefore it seems reasonable to assume that a transcription
factor of the AP-2 family mediates the stimulation of H19
transcription by retinoic acid.
As most of the sequence of the 5-kb human downstream
region (+6 to +11 kb) is unknown we are aware of the pos-
sibility that they may contain RARE sequence(s). Our results
clearly show that sequences 3P downstream of the human H19
polyadenylation site cooperate with 5P upstream regions in the
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Fig. 6. Activaton of CAT expression by H19 promoter and 3P
downstream sequences in NCCIT cells in the absence or presence of
all-trans retinoic acid. The cells were transiently transfected with
plasmids presented in Fig. 1. The cells were collected after 96 h and
CAT activity was analyzed. The CAT activity obtained by the H19
promoter alone is designated as 1. Identical results were obtained in
two independent experiments.
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regulation of the human H19 expression by retinoic acid as
was previously described to be the case for the mouse H19
gene by Yoo-Warren et al. [14].
It has also been proposed that retinoic acid can be respon-
sible for post-transcriptional regulation of the expression of a
gene such as connexin 43 by altering the stability of its
mRNA [28]. Such an assumption, however, cannot explain
the results in Fig. 6, showing that retinoic acid does not in-
crease CAT activity in cells transfected by a plasmid carrying
the CAT gene under the control of the H19 5P upstream
region alone.
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